Amphibian vertebrates are important models in regenerative biology
because they present exceptional regenerative capabilities throughout life.
However, it takes considerable effort to rear amphibians to juvenile and adult
stages for regeneration studies and the relatively large sizes that frogs and
salamanders achieve during development make them difficult to use in chemical
screens. Here we introduce a new tail regeneration model using late stage
Mexican axolotl embryos. We show that axolotl embryos completely regenerate
amputated tails in 7 days before they exhaust their yolk supply and begin to
feed. Further, we show that axolotl embryos can be efficiently reared in
microtiter plates to achieve moderate throughput screening of soluble chemicals
to investigate toxicity and identify molecules that alter regenerative outcome.
As proof of principle, we identified integration 1 / wingless (Wnt),
transforming growth factor beta (Tgf-β), and fibroblast growth factor
(Fgf) pathway antagonists that completely block tail regeneration and additional
chemicals that significantly affected tail outgrowth. Furthermore, we used
microarray analysis to show that inhibition of Wnt signaling broadly affects
transcription of genes associated with Wnt, Fgf, Tgf-β, epidermal growth
factor (Egf), Notch, nerve growth factor (Ngf), homeotic gene (Hox), rat
sarcoma/mitogen-activated protein kinase (Ras/Mapk), myelocytomatosis viral
oncogene (Myc), tumor protein 53 (p53), and retinoic acid (RA) pathways.
Punctuated changes in the expression of genes known to regulate vertebrate
development were observed; this suggests the tail regeneration transcriptional
program is hierarchically structured and temporally ordered. Our study
establishes the axolotl as a chemical screening model to investigate signaling
pathways associated with tissue regeneration.